Shares of Novo Nordisk gained 2.5% in premarket trade Monday after the drug manufacturer announced a new share buyback plan of up to 15 billion Danish Krone ($2.2 billion). Stock repurchases will be made over the next 12 months. Shares of Denmark-based Novo, which makes a suite of diabetes drugs, traded up around $45 premarket. They have risen more than 130% over the last year.
Copyright © 2015 MarketWatch, Inc.
Continue Reading Below